VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 0954391
Sex: F
Age:
State: GA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; headache; Tiredness; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL#246) second dose, via an unspecified route of administration on 08Jan2021 12:00 at single dose at right arm for COVID-19 immunisation. Medical history was none. No known allergies. Historical vaccine included bnt162b2 first dose on 18Dec2020 18:00 at single dose on left arm for COVID-19 immunisation. Concomitant medication included ascorbic acid (VITAMIN C). The patient experienced tiredness started on 08Jan2021 at 15:00, headache on 09Jan2021 at 14:00, fever on 09Jan2021 at 20:00. Patient received treatment ibuprofen for the events. Outcome of the events was resolving.

Other Meds: VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 0954392
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: maybe she could have COVID too; maybe she could have COVID too; a rash on her leg; some shortness of breath; This is a spontaneous report from a contactable consumer. A 72-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 06Jan2021 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received her first dose of COVID-19 vaccine on Wednesday, 06Jan2021 and today, on 09Jan2021, the patient started having a rash on her leg, some shortness of breath. She used an asthma inhaler. She experienced some of the symptoms before Wednesday. The reporter was concerned that maybe the patient could have COVID, too. The reporter heard that with COVID, sometimes rashes and/or shortness of breath can come, too. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0954393
Sex: M
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen Lymph Nords; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3246, via an unspecified route of administration at left arm on 08Jan2021 12:00 at single dose for COVID-19 immunization. Facility type vaccine was at military base. The patient medical history was not reported. Concomitant drugs was none. No other vaccine in four weeks or other medications in two weeks. The patient experienced swollen lymph nodes on 09Jan2021 15:00. No treatment received, no COVID prior vaccination and COVID was not tested post vaccination. The outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 0954395
Sex: F
Age:
State: AL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; fever; body aches; chills; night sweats; loss of appetite; This is a spontaneous report from a contactable Nurse (patient). A 24-year-old non-pregnant female patient received the second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), intramuscular on 07Jan2021 at 11:45 at single dose in left arm for covid-19 immunization. Medical history included birth control. Concomitant medication included fluoxetine hydrochloride (PROZAC), and ethinylestradiol, norgestimate (TRI LINYAH) for birth control. The patient previously received the first dose bnt162b2 (lot number: Et1a899), intramuscular on 16Dec2020 at 11:45 in left arm for covid-19 immunization. The patient experienced headache, fever, body aches, chills, night sweats, loss of appetite; all on 07Jan2021 at 12:00. The patient did not receive treatment for the events, all events were reported as non-serious. The patient did not receive other vaccine in four weeks. The patient did not have covid prior vaccination, and the patient was not tested for covid post vaccination. The outcome of all the events was resolved in Jan2021. No follow-up attempts are possible. No further information are expected.

Other Meds: PROZAC; TRI LINYAH

Current Illness:

ID: 0954396
Sex: U
Age:
State: MA

Vax Date:
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experienced extreme cold; fatigue; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was unknown whether the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown whether the patient received other medications in two weeks. The patient was not diagnosed with COVID-19 prior to vaccination. It was unknown whether the patient has been tested for COVID-19 since the vaccination. After the 2nd dose of BNT162B2, the patient experienced extreme cold and fatigue on 08Jan2021 with outcome of unknown. The events were reported as non-serious. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0954398
Sex: F
Age:
State: NY

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe headache behind the eyes; Initially extreme fatigue; started to have shortness of breath; muscle aches; cough; second dose on 05Jan2021 08:30; This is a spontaneous report from a contactable physician (patient). A 39-year-old female patient received second dose of BNT162B2 (Lot number: EL3246), intramuscularly on 05Jan2021 08:30 in left arm at single dose for COVID-19 immunization. Medical history included known allergies: latex and asthma. Patient did not have COVID prior vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), drospirenone/ethinylestradiol (YASMIN), melatonin, and ibuprofen (MOTRIN). Patient previously took montelukast sodium (SINGULAIR) and experienced allergy. Patient received first dose of BNT162B2 (Lot number: EK5730), intramuscularly on 18Dec2020 09:00 in left arm at single dose for COVID-19 immunization. Patient experienced initially extreme fatigue, then muscle ached all within 12-24 hours, severe headache behind the eyes. Then when thought was getting better, she started to have shortness of breath, worsening fatigue, and cough; all on 05Jan2021 12:00. These events were resulted in emergency room/department or urgent care. COVID was tested post vaccination. COVID test type post vaccination was nasal swab. COVID test name post vaccination was COVID 19 nasopharyngeal swan. COVID test date was on 08Jan2021. Test result was pending. Treatment received included nebulizer treatment, and steroid course. Patient was not recovered from these events.; Sender's Comments: Based on a compatible temporal relationship and known product safety profile, causality between events severe headache and extreme fatigue and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ZOLOFT; YASMIN; ; MOTRIN [IBUPROFEN]

Current Illness:

ID: 0954400
Sex: F
Age:
State: CO

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extreme fatigue a few hours after receiving the vaccine to where she couldn't keep her eyes open; Slight headache; This is a spontaneous report from a contactable nurse (patient herself). A 51-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL0142), via intramuscular on 05Jan2021 10:00 AM in right arm at single dose for covid-19 immunization. The patient medical history was not reported. There were no concomitant medications. Facility type vaccine was workplace clinic. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The patient previously took nitrofurantoin and experienced allergies: nitrofurantoin. The patient experienced extreme fatigue a few hours after receiving the vaccine to where she couldn't keep her eyes open and light headache on 05Jan2021 14:00. Outcome of events were recovering. No treatment was received for events.

Other Meds:

Current Illness:

ID: 0954401
Sex: M
Age:
State: KS

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever 101 degrees Fahrenheit; chills; muscle aches; This is a spontaneous report from a contactable other Health Professional (patient). A 27 years old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142) at his 26 years old, via an unspecified route of administration at left arm on 08Jan2021 19:15 at single dose for COVID-19 immunization. Medical history included depression, bipolar, dental implants, sinus surgery. No known allergies. Concomitant medication included vortioxetine hydrobromide (TRINTELLIX), bupropion (BUPROPION), acetylsalicylic acid, caffeine, salicylamide (EXCEDRIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever 101 degrees fahrenheit, chills, muscle aches on 09Jan2021 09:00 with outcome of not recovered. No treatment received for the adverse events. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19.

Other Meds: TRINTELLIX; ; EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]

Current Illness:

ID: 0954403
Sex: F
Age:
State: TX

Vax Date: 01/06/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 06/09/20 heart palpitations; dizziness; This is a spontaneous report from a contactable Other HCP (patient). A 30-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: Ek5730), via an unspecified route of administration in right arm on 06Jan2021 at 2nd single dose for COVID-19 immunization. Medical history included hoshimotos. No Covid prior vaccination. No known allergies. Historical vaccine included BNT162B2 on 16Dec2020 (1st dose) for COVID-19 immunization. Concomitant medication included levothyroxine, bupropion, desvenlafaxine succinate (PRISTIQ), topiramate (TOPIMAX). No other vaccine was received in four weeks. The patient experienced 06/09/20 heart palpitations and dizziness, both on 09Jan2021 11:15 with outcome of unknown. No Covid tested post vaccination.

Other Meds: ; ; PRISTIQ; TOPIMAX [TOPIRAMATE]

Current Illness:

ID: 0954405
Sex: F
Age:
State: IL

Vax Date: 12/17/2020
Onset Date: 12/17/2020
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bleeding at left arm injection site; Flu like symptoms; feeling unwell; fatigue; mild headache; injection site pain; injection site pain, increased soreness in 24 hrs; This is a spontaneous report from a contactable nurse. A 51-year-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EJ1685), intramuscular into the left arm on 17Dec2020 at 02:45 PM at single dose for COVID-19 immunization. Medical history included Childhood asthma, NIDDM and known allergies to Latex. Concomitant drugs included Metformin, Glyburide, Lisinopril, Jardiance, Januvia, Atorvastatin, Proventil, Advair, Tylenol, MVI, D3, Diosmin, Niacin, Flonase, Vit C. On 17Dec2020 after first dose administered, at 03:00 PM, the patient experienced injection site pain, increased soreness in 24 hrs, bleeding at left arm injection site; flu like symptoms at the 12th hour of vaccination despite of tylenol and ibuprofen alternate medication. Generalized feeling unwell, fatigue, mild headache. At the time of reporting, the patient was recovered.

Other Meds: ; GLYBURIDE; ; JARDIANCE; JANUVIA [SITAGLIPTIN PHOSPHATE]; ; PROVENTIL [SALBUTAMOL]; ADVAIR; MVI [ASCORBIC ACID;DEXPANTHENOL;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLA; D3; ; NIACIN; FLONASE [FLUTICASONE PROPION

Current Illness:

ID: 0954407
Sex: F
Age:
State: WV

Vax Date: 12/19/2020
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe chills, body shook and would not stop for about 2 hours; stomach hurt; This is a spontaneous report from a contactable Other Healthcare Professional (HCP, patient). This 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EH 9899), on Dec2020 (provided both as 19Dec2020 and 129Dec2020) at 10:00 PM at single dose, and the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EL 3248), on 09Jan2021 at 11:00 PM at single dose ,both for COVID-19 immunisation and via an unspecified route of administration. Age at vaccination was 36-years-old. Vaccine location was left arm for both doses. No other vaccine was received in four weeks. Medical history and concomitant medications were none. The patient had severe chills that started about 12 hours after the first vaccine (as reported). Her body shook and would not stop for about 2 hours. However onset was also reported as 09Jan2021 at 10:00PM (to be clarified). Treatment included Pepto bismol because her stomach hurt and she had ''dia'' (as reported). Outcome was recovering.

Other Meds:

Current Illness:

ID: 0954408
Sex: M
Age:
State: AL

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Gout in my left toe; This is a spontaneous report from a contactable patient. A 41-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Right arm on 06Jan2021 06:30 PM as a single dose for COVID-19 immunization, lot number: EJI685. Patient had no known allergies and had COVID prior vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Jan2021 07:00 AM patient experienced gout in his left toe, event resulted in emergency room/department or urgent care. Treatment received included colchicine (COLCRYS). Patient had not been tested for COVID-19 post vaccination. At the time of the report patient was recovering from the event.

Other Meds:

Current Illness:

ID: 0954409
Sex: F
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: could not move my arm; it was like glued to the side of my arm/such pain; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age (reported as 78: unknown unit) received her first dose of bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date not reported), via an unspecified route of administration on an unspecified date at SINGLE DOSE for Covid-9 immunisation. Medical history included hip replacement last year (2020) and informed that it was that much pain. The patient's concomitant medications were not reported. The patient reported that she could not move her arm. It was like glued to the side of her arm and informed that she never had such pain on an unspecified date. At the slightest touch she would scream. Her neighbor put her arm in a sling. She took Tylenol also as treatment. She was scheduled for her 2nd shot and was asking if this will happen again. The outcome of event was recovering (today was a little better). Information on the Lot/Batch number has been requested

Other Meds:

Current Illness:

ID: 0954411
Sex: F
Age:
State: GA

Vax Date: 12/22/2020
Onset Date: 01/07/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Jaundice; This is a spontaneous report from a contactable healthcare professional (patient). A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730), intramuscular in right arm on 22Dec2020 at a single dose for COVID-19 immunization. Medical history included almonds and apples allergy, Sulfa drugs allergy, and antibiotics allergy. The patient's concomitant medications were not reported. The patient previously took oxycodone hydrochloride;oxycodone terephthalate;paracetamol (PERCOCET) and VALIUM and experienced allergies. The patient experienced jaundice on 07Jan2021. Patient does not have COVID-19 prior vaccination. COVID-19 was not tested post vaccination. No treatment was received for the event. The outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 0954416
Sex: M
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm hurts a lot; his arm hurts a lot and it is hard for him to lift up his arm; put heat or ice on his injection site to relieve pain.; This is a spontaneous report from a contactable consumer (patient). A 76-year-old male patient of an unspecified age received the 1st dose of bnt162b2 (BNT162B2) at single dose on 09Jan2021 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced injection site pain and his arm hurts a lot and it is hard for him to lift up his arm. He placed an ice gel pack on the injection site to relieve pain in Jan2021. The outcome of events was unknown. He wanted to know if it matters which arm he receives the 2nd dose of the Covid vaccine in. He wanted confirmation that he is to receive the second dose of the vaccine in 3 weeks. Information on Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0954418
Sex: F
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever(highest 103.8); Chills; body aches; Muscle soreness; Headache; extreme fatigue; This is a spontaneous report from a contactable nurse reporting for herself. A 35-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 08Jan2021 at 11:00 at single dose in left arm for COVID-19 immunisation. Age at vaccination was 35 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. The patient was vaccinated at hospital. Historical vaccine included first dose of BNT162B2 administered on 18Dec2020 at 10:00 at single dose in left arm. Medical history included autoimmune thyroiditis (Hashimotos hypothyroidism), migraine, tachycardia/ palpitations. The patient has known allergies to tioconazole. Concomitant medications included sumatriptan succinate (IMITREX), propranolol (PROPANOLOL), levothyroxine sodium (SYNTHROID) and birth control. On 08Jan2021 at 07:00 PM, the patient experienced fever (highest 103.8), chills, body aches, muscle soreness, headache and extreme fatigue. No treatment was received for the events. The patient did not have COVID prior to vaccination and was not tested positive post vaccination. The events resolved on an unspecified date in Jan2021. Information on the lot/batch number has been requested.

Other Meds: IMITREX; PROPANOLOL [PROPRANOLOL]; SYNTHROID

Current Illness:

ID: 0954423
Sex: F
Age:
State: WA

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Fatigue; This is a spontaneous report from a contactable Nurse. A 30 Years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 07Jan2021 at 03:15 PM at single dose on right arm for COVID-19 immunization. Relevant medical history were not reported. Concomitant medication included unspecified multivitamins. The patient experienced fatigue on 09Jan2021 and headache on 10Jan2021. No treatment was received for the events. At the time of the reporting the patient had not yet recovered from the events. The information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0954424
Sex: F
Age:
State: MT

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Shaking chills; Significant headache 8/10 pain; temp of 101.5; Nausea; Emesis; Energy not quite back; This is a spontaneous report from a contactable Other-HCP (patient). This 54-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3246), via an unknown route, on 07Jan2021 (at 15:15) at single dose at left arm for COVID-19 immunisation, administered at hospital. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EH9899) on 18Dec2020. No other vaccine was received in four weeks. Relevant medical history included mild seasonal allergies. Patient allergies included erythromycin-hives. Relevant concomitant medications included colecalciferol (VITAMIN D), and cetirizine hydrochloride (ALLERTEC) as antihistamine therapy. Pre-vaccination and post-vaccination COVID tests were not performed. On 08Jan2021, after 12 hours of receiving the 2nd dose, the patient had shaking chills followed by significant headache 8/10 pain, temp of 101.5 and significant nausea with emesis, very difficult to take paracetamol (TYLENOL) or get in fluids. She was absolutely fitful for 30 hours. In bed wondering if it would stop, then after fever broke rest of symptoms slowly let up. Day three low grade temp of 98.9, energy not quite back but feeling better. The patient was not treated for the events. She was recovering from the events.

Other Meds: VITAMIN D [COLECALCIFEROL]; ALLERTEC

Current Illness:

ID: 0954426
Sex: F
Age:
State: IL

Vax Date: 12/29/2020
Onset Date: 12/31/2020
Rec V Date: 01/19/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hospitalized for stroke on 31Dec two days after vaccine.; sudden loss of hearing to right ear; dizzy and lightheaded/severe dizziness/felt like fainting; difficulty breathing; vomiting; This is a spontaneous report from a contactable nurse (patient). This 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (Lot number: EL1285) via intramuscular route on 29Dec2020 14:30 at single dose on the left arm for COVID-19 immunization. Medical history included anxiety. No known allergies. Concomitant medications were not reported. Patient was not pregnant. Facility type vaccine was Nursing Home/Senior Living Facility. No other vaccine received in four weeks. Patient hospitalized for stroke on 31Dec2020 two days after vaccine (Days of hospitalization: 4). Day of vaccine-6 hours after patient had dizzy and lightheaded for about 45 min then went away. On 31Dec2020 at 19:15 had sudden loss of hearing to right ear and severe dizziness, difficulty breathing, vomiting, and felt like fainting. Paramedics were called-sent to ER, had CTA which showed partial blockage and received TPA. Treatment included TPA, fluids, medications, hospital stay, outpatient follow ups, physical therapy. Patient was not diagnosed with COVID prior to vaccination. Patient has been tested for COVID post vaccination. The patient underwent lab tests and procedures which included Nasal Swab: Negative and Pixel: Negative on 08Jan2021. Outcome of the events was recovering.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported events including stroke, dizzy/lightheaded/felt like fainting, difficulty breathing, vomiting, and sudden loss of hearing to right, and the administration of the COVID-19 vaccine, BNT162B2. More information regarding the patient's underlying medical conditions, relevant lab tests would be helpful for the Company to make a more meaningful causality assessment.

Other Meds:

Current Illness:

ID: 0954428
Sex: F
Age:
State: TX

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant at the time of vaccination; Pregnant at the time of vaccination; Pregnant at the time of vaccination; bilateral nerve like pain; small headache; temp 100.3; enlarged axillary lymph nodes; pain in both shoulder joints; chest soreness; feel exhausted/feel tired; Braxton Hicks contractions; slight chills; injection site soreness/arm pain radiates around seems like nerve like pain with chest tightness; injection site soreness/arm pain radiates around seems like nerve like pain with chest tightness; arm pain radiates around seems like nerve like pain; This is a spontaneous report from a contactable other HCP. A 31-year-old female other HCP reported for herself that received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EKS730) into the left arm at single dose on 22Dec2020 at 05:30 PM and received the second dose of BNT162B2 (Lot number EKS730) into the left arm on 08Jan2021 at 08:00 AM at single dose for COVID-19 immunization. The patient is pregnant, last menstrual date 29Apr2020, gestational period 35 and estimated delivery date 07Feb2021. Concomitant drug included Prenatal vitamin. The patient reported that on 08Jan2021 she experienced injection site soreness at 20:00, the arm pain radiates around seems like nerve like pain with chest tightness. Temperature 97.7, she took Tylenol 1000 mg. On 09Jan2021 at 00:15 she had slight chills, at 01:20/01:30 chills, arm pain, chest more tight, Braxton Hicks contractions for about 1 hour, temperature 99.9, she took Tylenol 1000mg and went to sleep. At 08:00 she had no chills temperature 98.8, pain in both shoulder joints, chest soreness- feel exhausted. At 09:00 1000mg Tylenol, at 14:15 temperature 98.0, at 17:45 temperature 99.8, she took 750mg Tylenol. At 18:20 temperature 100.3, she took 250mg Tylenol, at 18:50 temperature 99.0 after shower, at 19:08 temp 98.8 and at 22:00 feeling slightly better, she had bilateral nerve like pain, chest pain, small headache. On 10Jan2021 at 02:45 temp 98.2 she took 1000mg Tylenol, at 09:00 temp 97.9, bilateral nerve like pain and enlarged axillary lymph nodes, chest sore, slight headache. At 17:00 temp 96.6 bilateral nerve/lymph node pain and felt tired. The patient did not have Covid prior vaccination and she was not Covid tested post vaccination. At the time of reporting the patient was recovering.

Other Meds: PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS

Current Illness:

ID: 0954429
Sex: M
Age:
State: NY

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mild flu-like illness; This is a spontaneous report from a contactable physician. A 69-years-old male patient started to receive bnt162b2 (BNT162B2) intramuscular on 07Jan2021 13:00 at SINGLE DOSE for covid-19 immunisation. Medical history included hypertension and degenerative joint disease (knees). Facility type vaccine: Hospital. vaccine location=Left arm, dose number 1. The patient's concomitant medications were not reported. The should be noted that patient had a covid-19 with an exposure date of 03Aug2020 with moderate symptoms lasting 2 weeks. The patient experienced mild flu-like illness on 08Jan2021 13:00 and lasting 20 hours with very abrupt termination of symptoms with outcome of recovered. The action taken was not applicable. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0954431
Sex: F
Age:
State: IL

Vax Date: 12/18/2020
Onset Date:
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; Headache; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE. lot number: EK5730), via an unspecified route of administration on 18Dec2020 10:45 in right arm at single dose for COVID-19 immunization. Medical history included Hashimotos thyroid disease and Mitral valve prolapse (MVP) from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID) and ferrous glycine sulfate (FE). The patient previously took Reglan iron infusions and experienced allergies. The patient experienced fatigue, headache and nausea on an unspecified date. The patient was not pregnant. The outcome of the event headache was not recovered and the outcome of the remaining events was unknown. The facility where the most recent COVID-19 vaccine was administered was in the hospital. Other medical history: hashimotos thyroid disease mvp

Other Meds: SYNTHROID; FE [FERROUS GLYCINE SULFATE]

Current Illness:

ID: 0954432
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Headaches; Fever; Skin sensitivity; Nausea; Feeling unwell; This is a spontaneous report from a contactable other health professional. A 22-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, in the left arm, from 06Jan2021 08:00 at a SINGLE DOSE for COVID-19 immunization. Medical history included rubber/latex allergy. The patient was not pregnant. The patient had her 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 16Dec2020 in the right arm and experienced injection site soreness/pain. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 07Jan2021 19:00, the patient experienced chills, headaches, fever (body temperature not provided), skin sensitivity, nausea and was feeling unwell. The outcome of events was reported as recovering. No treatment was received/required due to events. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0954434
Sex: F
Age:
State: NC

Vax Date: 12/22/2020
Onset Date: 01/10/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever 102 F; headache; chills; body aches; This is a spontaneous report from a contactable Nurse reported for herself. A 63-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on 22Dec2020 14:30 and the second dose single dose (lot number=EK9231) on 09Jan2021 19:15 for COVID-19 immunization. Vaccine location=Left arm, dose number 1 and dose number 2. Facility-type-vaccine: Hospital. Medical history included asthma. The patient's concomitant medications were not reported. On 10Jan2021 at 14:00 the patient experienced headache with outcome of not recovered, fever 102 ?F with outcome of not recovered, chills with outcome of not recovered and body aches with outcome of not recovered. The action taken was not applicable. Tylenol was received as therapeutic measures for fever.; Sender's Comments: Based on a compatible temporal association and known product safety profile, a causal relationship between reported events and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0954435
Sex: F
Age:
State: WI

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tenderness in armpit in the arm the vaccine was given; Possibly a lymph node reaction; This is spontaneous report from a contactable nurse (patient). This 23-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first single dose on 19Dec2020, second single dose on 08Jan2021, both intramuscular, in right arm, for COVID-19 immunization. No other vaccine was given in four weeks. Medical history included hc of SVT. The patient had no COVID19 before vaccination. The patient had no allergies. Concomitant medications included vitamin D, vitamin C and nylestradiol, levonorgestrel (ASHLYNA) for birth control. On 10Jan2021 at 08:00 the patient experienced tenderness in armpit in the arm the vaccine was given. The reporter was asking of a possible lymph node reaction. No treatment was given. COVID19 was not tested after vaccination. The events were resolving. Information on the lot/batch number has been requested.

Other Meds: VITAMIN D [COLECALCIFEROL]; VITAMIN C [ASCORBIC ACID]; ASHLYNA

Current Illness:

ID: 0954437
Sex: F
Age:
State: AR

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable other healthcare professional (HCP) (Patient). A 34-year-old female patient not pregnant received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Left arm on 08Jan2021 12:00 PM as a single dose for COVID-19 immunization, lot number: unknown. Medical history and concomitant medications were not provided. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. Patient had not been tested for COVID-19 post vaccination. On 10Jan2021 09:00 PM patient experienced severe itching that started in lower extremities and has moved up into trunk. Event was treated with diphenhydramine hydrochloride (BENADRYL). Patient was recovering from the event, at the time of the report. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0954438
Sex: M
Age: 64
State: CT

Vax Date: 01/07/2021
Onset Date: 01/15/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: none

Symptom List:

Symptoms: Muscle soreness in left arm for the first two days then marked fatigue on days 3-4, major urticaria developed on day 8 after vaccination with large patches of red, raised, very itchy rash on both sides of the anterior abdomen, with smaller patches on both of the lower legs and some on the posterior upper arms. The itching made sleep very difficult for the next two nights. The itching was decreased somewhat by the use of 1% hydrocortisone cream and moreso by 10 mg of Loratidine. The severity of the urticaria has decreased somewhat over the last 3 days since onset but is definitely still present.

Other Meds: none

Current Illness: none

ID: 0954439
Sex: M
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: None

Symptom List:

Symptoms: None stated.

Other Meds: Neupro: for Parkinson?s Rytary: for Parkinson?s D3 : 6000 IU C B complex CoQ10 Turmeric Magnesium Multivitamin Fiber well Probiotics E Fish Oil B-12

Current Illness: None

ID: 0954440
Sex: M
Age:
State: GA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: woke up with fever to 102F; rigors; body aches; headache; R arm pain and redness at injection site; R arm pain and redness at injection site; R arm pain and redness at injection site; the 1st dose on 22Dec2020, the 2nd dose on 08Jan2021; This is a spontaneous report from a contactable Physician (patient). This 32-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at the 1st dose on 22Dec2020, the 2nd dose (lot number: EL0142) on 08Jan2021; both at right arm via an unspecified route of administration at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. 12 hours after vaccine, the patient woke up with fever to 102F, rigors, body aches, and headache on 09Jan2021. Severe symptoms until around 24 hrs, then continued mild body aches and chills up to 50 hours after shot. Continued R arm pain and redness at injection site currently, at 72 hours after vaccine. No treatment was received for events. The patient had no COVID prior vaccination, no COVID tested post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of all events was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0954441
Sex: F
Age:
State: IN

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; earache; cough; chills; entire body aches/soreness; itchy red swollen rash on palms of hands, soles of feet, neck and right ear swelling/itching; itchy red swollen rash on palms of hands, soles of feet, neck and right ear swelling/itching; itchy red swollen rash on palms of hands; itchy red swollen rash on palms of hands, soles of feet, neck and right ear swelling/itching; right ear swelling/itching; right ear swelling/itching; This is a spontaneous report from a contactable Other HCP (patient). This 32-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at right arm on 08Jan2021 at single dose (lot number: e13246) for covid-19 immunisation. Medical history included PCOS, HSV2, ADHD, anxiety, depression. Concomitant medications included atenolol (NORTELOL), spironolactone, valaciclovir (VALACYCLOVIR), bupropion. The patient previously received erythromycin and experienced allergies, received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EH9899) at left arm on 14Dec2020 04:00 P.M for covid-19 immunisation. The patient experienced headache, earache, cough, chills, entire body aches/soreness, fatigue, Right arm pit tender/sore, itchy red swollen rash on palms of hands, soles of feet, neck and right ear swelling/itching on 09Jan2021 12:00 A.M. No treatment was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was recovering.

Other Meds: NORTELOL; ; VALACYCLOVIR [VALACICLOVIR];

Current Illness:

ID: 0954442
Sex: F
Age: 47
State: KY

Vax Date: 12/28/2020
Onset Date: 12/30/2020
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: PCN - rash

Symptom List:

Symptoms: Developed chest tightness around right side of chest into back and SOB 50.5 hours after vaccination. Went to local ER and found to have a right lower lobe pulmonary embolism. Treated with Xarelto and sent home with outpatient follow up.

Other Meds: Trintellix, Protonix, Singulair, Zyxal, Pulmicort, Trazodone, Melatonin

Current Illness: None

ID: 0954443
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: joint pain persisted; confusion; anorexia; chills began 19 hours after injection; low-grade fever (100.6); hypotension; hypoglycemia; lethargy; the 2nd dose on 08Jan2021 /1st dose on 20Dec2020; This is a spontaneous report from a contactable Physician (patient). This 72-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at left arm on 08Jan2021 05:00 PM at single dose (lot number: EK9231) for covid-19 immunisation. Medical history included diabetes, idiopathic encapsulating peritonitis and known allergies to Latex. Concomitant medications included insulin glargine (LANTUS), insulin lispro (HUMALOG), tamoxifen, apixaban (ELIQUIS), simvastatin. The patient previously received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) at left arm on 20Dec2020 01:00 PM for covid-19 immunisation. The patient experienced chills began 19 hours after injection, followed by low-grade fever (100.6), hypotension, hypoglycemia, lethargy, confusion and anorexia on 09Jan2021 12: 00 PM. Illness lasted 17 hours, treated with fluids, anti- inflammatories and sleep. Some new joint pain persisted. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the event joint pain persisted was unknown. Outcome of other events was recovered/resolved with sequel.

Other Meds: LANTUS; HUMALOG; ; ELIQUIS;

Current Illness:

ID: 0954444
Sex: M
Age: 34
State: NY

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: previously penicillin but has since taken without reaction, reaction was when I was 11/12 had red spots (like small leopard spots) up L arm and over shoulder down back to shoulder blade, rash had no other symptoms than other than discoloration. Took penicillin for tooth infection in 2017, no reaction, again in 2019 no reaction. Had reaction to debrox, red got swollen inflamed and itchy, when I was young, too young to remember age, never touched the stuff again. Also bee sting allergy, localized reaction red, warm swollen itchy.

Symptom List:

Symptoms: Fever as high as 103.6, chills, muscle aches, sore throat, diuresis, fatigue, shooting pains, general decent flu symptoms. as of yet... its only been 6 hours.

Other Meds: n/a

Current Illness: suspected sinus infection.

ID: 0954445
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sinus pain; diarrhea; abdominal pain; severe myalgia; headache; low grade fever; chills; general weakness; This is a spontaneous report from a non-contactable physician (patient). This 37-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at left arm on 08Jan2021 12:00 PM at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. The patient previous received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 25Dec2020 12:00 PM at left arm for covid-19 immunisation. At the first day on 09Jan2021, the patient experienced severe myalgia and headache, low grade fever and chills, general weakness. At the second day on 10Jan2021, the patient experienced headache and sinus pain, moderate myalgia, diarrhea and abdominal pain. At the third day on 12Jan2021, the patient experienced weakness. No treatment was received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Outcome of the events was recovered. No follow up attempts are possible; Information on the lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0954446
Sex: F
Age:
State: NE

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feel bad; Bad headache; Nausea; Dizzy happens when I move around and change position; Dizzy happens when I move around and change position; This is a spontaneous report from a contactable healthcare professional (patient). A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EH9899; Expiration date was not reported) on the left arm on 06Jan2021 (15:00) at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient had no relevant medical history. Concomitant medication included ibuprofen. On 07Jan2021 (12:30 AM), the patient had felt bad; bad headache; nausea; and was dizzy which happened when she moved around and changed position. The patient had received paracetamol (TYLENOL) and diphenhydramine (BENADRYL) as treatment for the reported adverse events. The outcome of the events, 'felt bad', 'bad headache', 'nausea' and 'dizzy which happened when she moved around and changed position', was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination, and had been tested since the vaccination. The patient had COVID-19 test which was negative on 08Jan2021.

Other Meds:

Current Illness:

ID: 0954447
Sex: M
Age: 42
State: IL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: NA

Symptom List:

Symptoms: Slight dizziness and tachycardia lasting for about 10 min

Other Meds: NA

Current Illness: NA

ID: 0954449
Sex: F
Age: 34
State:

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Sulfa-Hives

Symptom List:

Symptoms: Patient experienced lymphadenopathy in the supraclavicular and axillary lymph nodes as well as generalized malaise and arthralgias.

Other Meds: Vitamin D, Callogen

Current Illness: None

ID: 0954450
Sex: F
Age:
State: VA

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Could not raise it above shoulder, when turning steering wheel pain with up and over motion, could not lift anything; patient's left arm was very sore, achy; Bruise on injection site; This is a spontaneous report from a contactable other hcp. A 49-years-old female patient started to receive bnt162b2 (BNT162B2) , via an unspecified route of administration, lot number: EH9899, from 23Dec2020 11:00 at a SINGLE DOSE for COVID-19 immunization. Medical history included obesity, hyperthyroid and vit d deficiency. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included topiramate (TOPAMAX), bupropion, darifenacin (ENABLEX) and levothyroxine. On 23Dec2020 15:00, the patient's left arm was very sore, achy, could not raise it above shoulder, when turning steering wheel pain with up and over motion, could not lift anything. Pain was described as worse than flu shot which lasted 24 hours. She also had bruise on injection site that lasted two weeks. Outcome of events was recovered. No treatment was received/required due to events. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: TOPAMAX; ; ENABLEX [DARIFENACIN];

Current Illness:

ID: 0954451
Sex: M
Age:
State: OR

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Temperature spike to 104.6; received first dose of bnt162b2 on 20Dec2020 and second dose on 08Jan2021 13:15; This is a spontaneous report from a contactable consumer. A 38-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration, on the left arm on 08Jan2021 13:15 at a single dose for COVID-19 immunization. Medical history included prediabetic kidney disease. Concomitant medications included salmo salar oil (OMEGA-3 [SALMO SALAR OIL]), lisinopril, furosemide, escitalopram, and rosuvastatin calcium (CRESTOR). The patient is reported to have received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 20Dec2020 15:45, on the left arm, for COVID-19 immunization. The patient had no prior Covid vaccination. The patient was not tested for Covid post vaccination. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that the patient received first dose of bnt162b2 on 20Dec2020 and second dose on 08Jan2021 13:15. On 09Jan2021 at 04:30, the patient experienced temperature spike to 104.6, brought down with TYLENOL to hover around 101.0 to 102.0 for 24 hours, normal after that. The patient called a nurse who instructed to go the emergency room/physician office visit. Outcome of the event Temperature spike to 104.6 was recovered on unspecified date in Jan2021. Information about lot/batch number has been requested.

Other Meds: OMEGA-3 [SALMO SALAR OIL]; ; ; ; CRESTOR

Current Illness:

ID: 0954452
Sex: F
Age: 27
State: AZ

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Dairy, pollen, latex, adhesives, Penicillin (mild)

Symptom List:

Symptoms: Dizziness/light-headed, difficulty speaking, difficulty swallowing, mild tongue and throat swelling, constant need to clear throat, tingle/tickle in throat

Other Meds: Albuterol inhaler, generic Zertec, Flintstone's Immunity Support vitamins, and Hair, Skin and Nails gummy vitamins

Current Illness:

ID: 0954453
Sex: F
Age:
State: NY

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle aches; headache; soreness on left arm; felt cold in the evening of 08Jan2021; feels like having a fever/fever of 101.4F; This is a spontaneous report from a contactable healthcare professional (patient). A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EK9231, unknown expiration), via an unspecified route of administration in left arm, on 08Jan2021 at 09:15, at single dose, for COVID-19 immunization. Medical history included palpitations and COVID-19 on 26Mar2020 (Prior to vaccination, was the patient diagnosed with COVID-19: Yes). On 26Mar2020, the patient had nasal swab for COVID-19 which is positive. The patient has no known allergies to medications, food, or other products. Concomitant medications included ascorbic acid (VIT C), metoprolol, and unspecified multivitamins. The patient felt cold in the evening of 08Jan2021 at 20:00, feels like having a fever. The next morning (09Jan2021), the patient had a fever of 101.4F, muscle aches, headache and soreness on left arm. The patient took Tylenol, lots of fluids and bed rest. The patient started feeling better on 10Jan2021. COVID-19 vaccine was administered in a hospital. The patient is not pregnant at the time of vaccination. The patient was diagnosed with COVID-19 prior to vaccination. On unspecified date, the patient was tested for COVID post vaccination (COVID-19 PCR) with unknown result. The patient did not receive other vaccine in four weeks. The patient recovered from the events in Jan2021.

Other Meds: VIT C;

Current Illness:

ID: 0954454
Sex: F
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for COVID; tested positive for COVID; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient who is a nurse visited last weekend in the reporter's home for a few hours was advised that she tested positive for COVID today (unspecified date) and her family as well. She was vaccinated recently with the Pfizer vaccine. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0954455
Sex: M
Age: 60
State: OK

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: None

Symptom List:

Symptoms: I had fever and severe chills/ shaking

Other Meds: Brilinta, atorvastatin, aspirin, carvedilol, femotidine

Current Illness: Had covid approx 2 weeks before vaccine

ID: 0954456
Sex: F
Age:
State: MA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Malaise; Hives; Other vaccine same date details: [{other vaccine same date product= Pfizer/Bio, other vaccine same date vaccine date= 08Jan2021}]; Other vaccine same date details: [{other vaccine same date product= Pfizer/Bio, other vaccine same date vaccine date= 08Jan2021}]; This is a spontaneous report from a contactable other hcp. A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number unknown, intramuscular on 08Jan2021 11:30 at a SINGLE DOSE and via an unspecified route of administration on 08Jan2021 at a SINGLE DOSE for covid-19 immunisation. Other vaccine same date details: [{other vaccine same date product= Pfizer/Bio, other vaccine same date vaccine date= 08Jan2021}]. Medical history included drug hypersensitivity to Penicillin from an unknown date and unknown if ongoing. Concomitant medication included lisinopril (LISINOPRIL) and atorvastatin (ATORVASTATIN). The patient previously took clindamycin and experienced drug hypersensitivity. The patient experienced Hives, Chills, Malaise on 08Jan2021 18:00. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds: ;

Current Illness:

ID: 0954457
Sex: M
Age: 53
State:

Vax Date: 12/21/2020
Onset Date: 12/29/2020
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Ceftin

Symptom List:

Symptoms: I have had 5 nose bleeds in the past 2 weeks, the first occurring 8 days after dose 1 of the Pfizer COVID vaccine. I hadn?t had a nose bleed prior to that for at least 10 years and I?ve been on the same low dose aspirin dose once daily for several years. No petechiae, bruising or other bleeding.

Other Meds: Verapamil, Lotensin-HCT, atorvastatin, aspirin, famotidine, Alcestis, albuterol

Current Illness: None

ID: 0954458
Sex: F
Age:
State: ME

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; Severe fever (104.6); chills; nausea; muscle soreness; first dose of BNT162B2 on 22Dec2020, second dose on 09Jan2021; This is a spontaneous report from a contactable nurse. A 29-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3302), via an unspecified route of administration on 09Jan2021 at 07:30 at a single dose on the right arm for COVID-19 immunization. The patient's medical history was not reported. The patient has no allergies to medications, food, or other product. There were no concomitant medications. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1284) on 22Dec2020 at 02:00 pm on the right arm for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 09Jan2021 at 20:00, the patient experienced fatigue, severe fever (104.6), chills, nausea, and muscle soreness. The patient did not receive any treatment for the reported events. Since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0954459
Sex: F
Age:
State: CA

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills and rigor; fever/febrile; headache; nausea; whole body muscle aches; This is a spontaneous report from a non-contactable nurse (patient). A 30-year-old adult female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: Ej1686), via an unspecified route of administration on 10Jan2021 10:30 AM at single dose on the left arm for COVID-19 immunisation. The patient is not pregnant at the of report. COVID-19 vaccine was administered in the hospital. Medical history included migraine, Polycystic ovarian syndrome (Pcos), seasonal allergies, penicillin and sulfa antibiotics allergies. Concomitant medications (Other medications in two weeks) included levothyroxine sodium (SYNTHROID), spironolactone, montelukast sodium (SINGULAIR), loratadine (CLARITIN [LORATADINE]) and calcium levomefolate (DEPLIN). The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: Ej1685) on 21Dec2020 03:15 PM on the left arm. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior vaccination. The patient reported that on 11Jan2021 12:00 AM, 14 hours post receiving the second dose, she had chills and rigor and ended up with a fever. Patient took Tylenol, fever broke and 4 hours later again had chills and rigor febrile again and took ibuprofen. The patient also had headache, nausea, and whole body muscle aches. The events were assessed as non-serious. Outcome of the events was recovering. The patient has not been tested for COVID-19 since the vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds: SYNTHROID; ; SINGULAIR; CLARITIN [LORATADINE]; DEPLIN

Current Illness:

ID: 0954460
Sex: F
Age: 29
State: GA

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: No

Symptom List:

Symptoms: I received the first dose of the COVID 19 (Moderna) on 01/15/2021 in the evening. The next morning I woke up at 05:45am with a sore arm, which I was told was one of the side effect. However I was sore and aching all over my body. As my day continued, I became tired and feeling flushed within the face. I felt my heart rate beating faster than normal. I began having cold chills and the aching within my body progressed through out the day (12 hr shift). When I clocked out at 07:08 pm and got home from work, I was unable to hardly move with out hurting and I felt like I had a fever. My husband checked my temperature and I had a low grade temp of 99.4 with an increase work of breathing and had ,a difficult time catching a breath. My husband took me to the hospital ER and before arriving to the ER I was having a stridor episode and when the nurse checked my temperature it read 102.3. I could not complete a full sentence and began vomiting. I was given epinephrine nebulized, solumedrol, benadryl, zofran, lidocaine nebulized. I had a CT with contrast of my neck and a chest xray. All images came back normal, I had been treated for an allergic reaction from the COVID vaccine and discharged home once the symptoms and stridor subsided.

Other Meds: No

Current Illness: No

ID: 0954461
Sex: F
Age:
State: AR

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: generalized body soreness.; severe migraine; severe weakness; left arm (same arm she received vaccine) broke out in a red itchy rash; red itchy rash; feeling hot; dry heaving; severe painful coughing; severe painful coughing lasted about an hour along with post nasal drip appearing; within 2 hours my skin became blotchy and itchy; within 2 hours my skin became blotchy and itchy; This is a spontaneous report from a contactable nurse (patient). A 26-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142 and expiry date: unknown), via an unspecified route of administration on the left arm on 05Jan2021 17:30 at a single dose for COVID-19 immunization. Medical history included autoimmune progesterone dermatitis, Reynaud's syndrome, skin mottling, gastrooesophageal reflux disease (GERD), migraines, post-traumatic stress disorder (PTSD), sulfa allergy, and depression. Patient was not pregnant. The patient's concomitant medications included PEPCID. The patient previously took progesterone, miconazole and hydroxychloroquine sulfate (PLAQUENIL) and experienced allergy.The patient experienced within 2 hours her skin became blotchy and itchy on 05Jan2021 18:45. She took a shower and symptoms resolved. Next morning on 06Jan2021, patient's left arm (same arm she received vaccine) broke out in a red itchy rash. She took Prednisone 40mg around 10am and rash resolved. Around 3-4pm the rash reappeared along with feeling hot on the same day. She ran outside and began dry heaving and coughing. The severe painful coughing lasted about an hour along with post nasal drip appearing on 06Jan2021. During that hour patient took Zofran,12 puffs of Albuterol total, and Benzedrex nasal spray. She was already on Pepcid 20mg- 2 tablets BID for GERD prior to reaction; cough improved. On 07Jan2021, around 2-3am morning woke up with a severe migraine and cough returned along with severe weakness. Patient went to the clinic she worked and received steroid shots to help along with Maxalt and more Albuterol. By Sunday, 10Jan2021, she was almost back to base like, generalized body soreness. Monday (11Jan2021) back to base line for the most part. The patient underwent lab tests and procedures which included nasal swab: negative on 08Jan2021. Outcome of the events was recovered with sequel. The reporter considered the events as non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had been tested since the vaccination.

Other Meds:

Current Illness:

ID: 0954462
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/19/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She is anaphylactic to some ingredients of the pneumonia shot a few years ago; This is a spontaneous report from a contactable consumer (parent). A female patient (daughter) received Pneumococcal 13-Val Conj Vac (Dipht Crm197 Protein) (Lot/Batch Number and Expiration Date unknown) via unspecified route of administration on an unspecified date at single dose for immunisation. The patient's medical history and concomitant medications was not reported. Patient was a front liner and was supposed to get the vaccine last week. However, she was anaphylactic to some ingredients of the pneumonia shot a few years before unspecified date, but does not know which specific ingredient. Patient wanted to know the ingredients of the covid vaccine so that they may cross check it with their pharmacist. The outcome of event was unknown. Pfizer is a marketing authorization holder of Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein) in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein) has submitted the same report to the regulatory authorities. Information on the batch number has been requested.; Sender's Comments: A possible causal association between administration of Pneumococcal 13-Val Conj Vaccine and the onset of anaphylactic reaction might not be fully excluded, considering the known adverse event profile of the suspect product. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm